Wacker Biotech US and Expression Manufacturing have partnered to advance the development and manufacturing of lentiviral-based gene and cell therapies, providing an end-to-end solution for viral vector development and production. Wacker Biotech will offer its PLASMITEC® platform, microbial fermentation lines and pDNA capabilities. Expression will bring its LentET™ platform and viral vector manufacturing capabilities to the collaboration.
CRISPR at 25: The Past, Present, and Future of Genome Editing
Register Now Panelists: Rodolphe Barrangou, PhD North Carolina State University View Bio Panelist Rodolphe Barrangou, PhD Rodolphe Barrangou, PhD, is the T. R. Klaenhammer Distinguished
